These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 18703006

  • 1. Grey matter pathology in multiple sclerosis.
    Geurts JJ, Barkhof F.
    Lancet Neurol; 2008 Sep; 7(9):841-51. PubMed ID: 18703006
    [Abstract] [Full Text] [Related]

  • 2. Grey matter pathology in multiple sclerosis.
    Bö L, Geurts JJ, Mörk SJ, van der Valk P.
    Acta Neurol Scand Suppl; 2006 Sep; 183():48-50. PubMed ID: 16637929
    [Abstract] [Full Text] [Related]

  • 3. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, Yousry TA, Miller DH.
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [Abstract] [Full Text] [Related]

  • 4. Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.
    Magliozzi R, Howell OW, Durrenberger P, Aricò E, James R, Cruciani C, Reeves C, Roncaroli F, Nicholas R, Reynolds R.
    J Neuroinflammation; 2019 Dec 07; 16(1):259. PubMed ID: 31810488
    [Abstract] [Full Text] [Related]

  • 5. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
    Lassmann H.
    Exp Neurol; 2010 Sep 07; 225(1):2-8. PubMed ID: 19840788
    [Abstract] [Full Text] [Related]

  • 6. Gray matter pathology in (chronic) MS: modern views on an early observation.
    Geurts JJ, Stys PK, Minagar A, Amor S, Zivadinov R.
    J Neurol Sci; 2009 Jul 15; 282(1-2):12-20. PubMed ID: 19249061
    [Abstract] [Full Text] [Related]

  • 7. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
    Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P.
    J Neuropathol Exp Neurol; 2007 Aug 15; 66(8):732-9. PubMed ID: 17882017
    [Abstract] [Full Text] [Related]

  • 8. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.
    Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, Aloisi F, Reynolds R.
    Ann Neurol; 2010 Oct 15; 68(4):477-93. PubMed ID: 20976767
    [Abstract] [Full Text] [Related]

  • 9. Cortical lesion load associates with progression of disability in multiple sclerosis.
    Calabrese M, Poretto V, Favaretto A, Alessio S, Bernardi V, Romualdi C, Rinaldi F, Perini P, Gallo P.
    Brain; 2012 Oct 15; 135(Pt 10):2952-61. PubMed ID: 23065788
    [Abstract] [Full Text] [Related]

  • 10. Association of alpha-synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions.
    Lu JQ, Fan Y, Mitha AP, Bell R, Metz L, Moore GR, Yong VW.
    J Neuropathol Exp Neurol; 2009 Feb 15; 68(2):179-89. PubMed ID: 19151622
    [Abstract] [Full Text] [Related]

  • 11. Exploring the origins of grey matter damage in multiple sclerosis.
    Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, Martin R.
    Nat Rev Neurosci; 2015 Mar 15; 16(3):147-58. PubMed ID: 25697158
    [Abstract] [Full Text] [Related]

  • 12. The histopathology of grey matter demyelination in multiple sclerosis.
    Bø L.
    Acta Neurol Scand Suppl; 2009 Mar 15; (189):51-7. PubMed ID: 19566500
    [Abstract] [Full Text] [Related]

  • 13. Gray matter involvement in multiple sclerosis.
    Pirko I, Lucchinetti CF, Sriram S, Bakshi R.
    Neurology; 2007 Feb 27; 68(9):634-42. PubMed ID: 17325269
    [Abstract] [Full Text] [Related]

  • 14. Meningeal and cortical grey matter pathology in multiple sclerosis.
    Popescu BF, Lucchinetti CF.
    BMC Neurol; 2012 Mar 07; 12():11. PubMed ID: 22397318
    [Abstract] [Full Text] [Related]

  • 15. Measurement and clinical effect of grey matter pathology in multiple sclerosis.
    Geurts JJ, Calabrese M, Fisher E, Rudick RA.
    Lancet Neurol; 2012 Dec 07; 11(12):1082-92. PubMed ID: 23153407
    [Abstract] [Full Text] [Related]

  • 16. Cortical pathology in multiple sclerosis.
    Stadelmann C, Albert M, Wegner C, Brück W.
    Curr Opin Neurol; 2008 Jun 07; 21(3):229-34. PubMed ID: 18451703
    [Abstract] [Full Text] [Related]

  • 17. Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space.
    Howell OW, Schulz-Trieglaff EK, Carassiti D, Gentleman SM, Nicholas R, Roncaroli F, Reynolds R.
    Neuropathol Appl Neurobiol; 2015 Oct 07; 41(6):798-813. PubMed ID: 25421634
    [Abstract] [Full Text] [Related]

  • 18. Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
    Gardner C, Magliozzi R, Durrenberger PF, Howell OW, Rundle J, Reynolds R.
    Brain; 2013 Dec 07; 136(Pt 12):3596-608. PubMed ID: 24176976
    [Abstract] [Full Text] [Related]

  • 19. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
    Chard D, Miller D.
    J Neurol Sci; 2009 Jul 15; 282(1-2):5-11. PubMed ID: 19201002
    [Abstract] [Full Text] [Related]

  • 20. [Neuronal injury in multiple sclerosis].
    Correale J, Meli F, Ysrraelit C.
    Medicina (B Aires); 2006 Jul 15; 66(5):472-85. PubMed ID: 17137182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.